|
|
|
|
LEADER |
00000pam a2200000 a 4500 |
001 |
3672745 |
003 |
ICU |
005 |
20030527132500.0 |
008 |
980727s1999 nyua b 001 0 eng |
010 |
|
|
|a 98039465
|
020 |
|
|
|a 0824701887 (alk. paper)
|
035 |
|
|
|a (NhCcYBP)YBT 98039465
|
035 |
|
|
|a (NhCcYBP)YBP99088170742
|
040 |
|
|
|a DLC
|c DLC
|d DLC
|d OrLoB-B
|d OCoLC
|
050 |
0 |
0 |
|a RC588.I45
|b A43 1999
|
082 |
0 |
0 |
|a 616.97/06
|2 21
|
245 |
0 |
0 |
|a Allergens and allergen immunotherapy /
|c edited by Richard F. Lockey, Samuel C. Bukantz.
|
250 |
|
|
|a 2nd ed., rev. and expanded.
|
260 |
|
|
|a New York :
|b Marcel Dekker,
|c c1999.
|
300 |
|
|
|a xix, 609 p. :
|b ill. ;
|c 26 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
440 |
|
0 |
|a Clinical allergy and immunology
|v 12
|
500 |
|
|
|a Rev. ed. of: Allergen immunotherapy. 1st ed. 1991.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|t Series Introduction /
|r Michael A. Kaliner --
|g 1.
|t Allergen Immunotherapy in Historical Perspective /
|r Sheldon G. Cohen and Richard Evans III --
|g 2.
|t Definition of an Allergen (Immunobiology) /
|r Malcolm N. Blumenthal and Andreas Rosenberg --
|g 3.
|t Aerobiology /
|r W. Elliott Horner, Samuel B. Lehrer and John E. Salvaggio --
|g 4.
|t Allergen Nomenclature /
|r Martin D. Chapman --
|g 5.
|t Tree Pollen Allergens /
|r Rudolf Valenta, Verena Niederberger and Sabine Fischer [et al.] --
|g 6.
|t Grass Pollen Allergens /
|r Robert E. Esch --
|g 7.
|t Weed Pollen Allergens /
|r Shyam S. Mohapatra and Richard F. Lockey --
|g 8.
|t Mold Allergens /
|r Hari M. Vijay, Ajay J. Thaker and Banani Banerjee [et al.] --
|g 9.
|t Hymenoptera Allergens /
|r Te Piao King and Miles Guralnick --
|g 10.
|t Biting Insect Allergens /
|r Donald R. Hoffman --
|g 11.
|t Mite Allergens /
|r Enrique Fernandez-Caldas, Leonardo Puerta and Richard F. Lockey --
|g 12.
|t Cockroach and Other Inhalant Insect Allergens /
|r Ricki M. Helm --
|g 13.
|t Mammalian Allergens /
|r Carsten Schou --
|g 14.
|t Food Allergens /
|r A. Wesley Burks --
|g 15.
|t Latex Allergens /
|r Jay E. Slater --
|g 16.
|t Drug Allergens, Haptens, and Anaphylatoxins /
|r Badrul A. Chowdhury and Phillip L. Lieberman --
|g 17.
|t Manufacturing and Standardizing Allergen Vaccines /
|r Jorgen Nedergaard Larsen, Tomas Wikborg and Manuel Lombardero Vega [et al.] --
|g 18.
|t Allergen Vaccine Unitage Based on Biological Standardization: Clinical Significance /
|r Paul C. Turkeltaub --
|g 19.
|t Immunological Responses to Allergen Immunotherapy /
|r Stephen R. Durham and Qutayba A. Hamid --
|g 20.
|t Efficacy of Immunotherapy /
|r Dennis K. Ledford --
|g 21.
|t Patient Selection for Allergen Immunotherapy: When to Start and Stop /
|r David E. Parry and Robert K. Bush --
|g 22.
|t Preparing and Mixing Allergen Vaccines /
|r Harold S. Nelson --
|g 23.
|t Administration of Inhalant Allergen Vaccines /
|r Leslie C. Grammer, Martha A. Shaughnessy and Roy Patterson --
|g 24.
|t Administering Hymenoptera Venom and Vaccines of Biting Insect Allergen /
|r Pascal Demoly and Jean Bousquet --
|g 25.
|t Pharmacoeconomic Considerations for Allergen Immunotherapy /
|r Jonathan A. Bernstein --
|g 26.
|t Potential New Forms of Immunotherapy /
|r Philip S. Norman and Alkis Togias --
|g 27.
|t Recombinant Allergens: A New Form of Immunotherapy? /
|r Christof Ebner --
|g 28.
|t Unproven and Controversial Forms of Immunotherapy /
|r Abba I. Terr --
|g 29.
|t In Vitro Tests To Monitor Efficacy of Immunotherapy in IgE-Mediated Disease /
|r John W. Yunginger --
|g 30.
|t In Vivo Provocation Testing for IgE-Mediated Disease /
|r Peter S. Creticos --
|g 31.
|t Adverse Effects and Fatalities Associated with Allergen Immunotherapy /
|r Samuel C. Bukantz, Richard F. Lockey and Giana L. Nicoara-Kasti --
|g 32.
|t Anaphylaxis and Anaphylactoid Reactions /
|r Stephen F. Kemp and Richard D. deShazo --
|g 33.
|t Selected Immunotherapy Patient Instructions and Consent Forms /
|r Robert P. Nelson, Jr. and Richard F. Lockey.
|
650 |
|
0 |
|a Allergy
|x Immunotherapy.
|
650 |
|
0 |
|a Allergens
|x Therapeutic use.
|
650 |
|
7 |
|a Allergens
|x Therapeutic use.
|2 fast
|0 http://id.worldcat.org/fast/fst00805545
|
650 |
|
7 |
|a Allergy
|x Immunotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00805561
|
700 |
1 |
|
|a Lockey, Richard F.
|0 http://id.loc.gov/authorities/names/n80053024
|1 http://viaf.org/viaf/91693639
|
700 |
1 |
|
|a Bukantz, Samuel C.
|0 http://id.loc.gov/authorities/names/n85158975
|1 http://viaf.org/viaf/49392380
|
730 |
0 |
|
|a Allergen immunotherapy.
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
903 |
|
|
|a Hathi
|
035 |
|
|
|a (OCoLC)39633892
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 9af92623-763e-52dd-920b-e7ec9641fe0f
|s 9dfaa7cb-996c-5296-9079-4c046c4c4410
|
928 |
|
|
|t Library of Congress classification
|a RC588.I45 A43 1999
|l JCL
|c JCL-Sci
|i 3636596
|
927 |
|
|
|t Library of Congress classification
|a RC588.I45 A43 1999
|l JCL
|c JCL-Sci
|e CRERAR
|b 50227131
|i 6095595
|